Seelos Therapeutics (SEEL)
(Delayed Data from NSDQ)
$1.20 USD
-0.02 (-1.64%)
Updated May 31, 2024 04:00 PM ET
After-Market: $1.18 -0.02 (-1.67%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Seelos Therapeutics, Inc. [SEEL]
Reports for Purchase
Showing records 61 - 65 ( 65 total )
Company: Seelos Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Seelos Therapeutics, Inc.
Industry: Medical - Drugs
Hospitalization Rates Due to Suicidality On the Rise
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Seelos Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Seelos Therapeutics, Inc.
Industry: Medical - Drugs
Proof of Racemic Ketamine Is in the Pudding; Initiating with Buy
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Seelos Therapeutics, Inc.
Industry: Medical - Drugs
Forget What You''''ve Heard on the Streets; Initiating With a Buy and $4 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V